Describes a group of key strategic decisions confronting the scientific founder and CEO of a promising, early phase bio-pharmaceuticals business.
Should the business produce a proposed alliance with a pharmaceutical firm? Should it generate a nutraceuticals company in parallel to its attempt to come up with anti-aging therapeutics? And, should it in-license another drug development candidate?
Sirtris Pharmaceuticals Living Healthier, Longer (Abridged) case study solution
PUBLICATION DATE: October 04, 2012 PRODUCT #: 813029-PDF-ENG
This is just an excerpt. This case is about INNOVATION & ENTREPRENEURSHIP
Related Case Solutions & Analyses:
Measure of Delight: The Pursuit of Quality at AT&T Universal Card Services (B)
Bose Corp.: The JIT II Program (A)
Orthoteks US(D)
T. Harris Photography
China Post
Note on Agriculture in Argentina
Vizio: Entry and Growth in Television Market
BRAC in 2014
Elia Nuqul and the Making of a Middle Eastern Business Group (A)
Marissa Mayer at Google
